mRNA/SOL
Skóre | 28 |
|---|---|
Obj za 24 h | 619,8 $ |
Likvidita | 2,1 tis. $ |
Vlastníci | 95 |
Audity | |
Věk | 2 dny |
FDV | 2 tis. $ |
Tržní kap | 2 tis. $ |
| Adresy | |
|---|---|
| Pool | |
| mRNA | |
| SOL |  |
| Vývojář |
Konvertor z mRNA do SOL
Skóre | 28 |
|---|---|
Obj za 24 h | 619,8 $ |
Likvidita | 2,1 tis. $ |
Vlastníci | 95 |
Audity | |
Věk | 2 dny |
FDV | 2 tis. $ |
Tržní kap | 2 tis. $ |
Moderna Inc (mRNA)
Recent discussions on mRNA technology have been fueled by announcements from Oracle CEO Larry Ellison about the potential of AI in designing personalized mRNA vaccines for cancer treatment, sparking both interest and controversy on X. Oracle CEO Larry Ellison discussed at the White House how AI could soon design personalized mRNA vaccines for individuals to combat cancer, highlighting the promise of AI in healthcare. This announcement has led to a mix of reactions on X, with some users expressing skepticism or outright opposition to mRNA vaccines due to past experiences with COVID-19 mRNA vaccines, while others see potential in the technology for personalized medicine. The debate on X reflects broader concerns about the safety, efficacy, and ethical implications of mRNA technology, especially in light of its rapid development and application during the COVID-19 pandemic.
Aktualizace informací o tokenuCenové statistiky pro mRNA/SOL
Současná cena mRNA (mRNA/SOL) na burze PumpSwap je 0,000002016 $. Cena je o -5,6 % vyšší než za posledních 24 hodin. Hlášený objem obchodování za posledních 24 hodin je 619,80 $ s celkovým počtem transakcí: 24. Adresa kontraktu mRNA/SOL je 8PuiDczBmQuTHtwK4YjtRsViQ74hE2jKZY4ib7wrfxN2, valuace po uvolnění všech tokenů (FDV) je 2 015,63 $ a pool likvidity je 2 149,94 $.
